1-[(4-Fluorophenyl)methyl]azetidin-3-ol

Catalog No.: 
ACAHEP625
CAS No.: 
111043-49-3
Molecular Formula: 
C10H12FNO
Molecular Weight: 
181.21
1-[(4-Fluorophenyl)methyl]azetidin-3-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$228.00InquiryInquiry
250mg95%$491.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(4-Fluorophenyl)methyl]azetidin-3-ol
IUPAC Name1-(4-fluorobenzyl)azetidin-3-ol
MDL No.-
Molecular FormulaC10H12FNO
Molecular Weight181.21
SMILESOC1CN(CC2=CC=C(F)C=C2)C1
InChI KeyJKNYOFXNAYHDJV-UHFFFAOYSA-N
Synonym1-[(4-Fluorophenyl)methyl]-3-azetidinol;1-[(4-fluorophenyl)methyl]azetidin-3-ol;3-Azetidinol, 1-[(4-fluorophenyl)methyl]-;1-(4-fluorobenzyl)azetidin-3-ol
CAS No.111043-49-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAHEP625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICXL305 route compound structure diagram
    ACICXL30518621-18-6In Stock
  4. Then
  5. ACAHEP625 route product structure diagram
    ACAHEP625111043-49-3
Inquiry

2. ACAHEP625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACICXL305 route compound structure diagram
    ACICXL30518621-18-6In Stock
  4. Then
  5. ACAHEP625 route product structure diagram
    ACAHEP625111043-49-3
Inquiry

3. ACAHEP625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAHEP625 route product structure diagram
    ACAHEP625111043-49-3
Inquiry

Comments (0)